Research Article
Renal Protective Effect of DPP-4 Inhibitors in Type 2 Diabetes Mellitus Patients: A Cohort Study
Table 2
Changes in UACR, HbA1c, eGFR, and lipid profiles 1 year before and 1 year after DPP-4i treatment initiation.
| ||||||||||||||||||||||||||||||||||||||||||||
Data are presented as means ± standard deviation. ‡The paired Student’s -test was performed to evaluate changes in each parameter from baseline to 1 year before DPP-4i treatment and 1 year after treatment initiation. DPP-4i: dipeptidyl-peptidase IV inhibitor; eGFR: estimated glomerular filtration rate; HbA1c: glycosylated hemoglobin; HDL: high density lipoprotein; LDL: low density lipoprotein; UACR: urine albumin/creatinine ratio. |